HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Marat V Ezhov Selected Research
Marat V Ezhov Research Topics
Disease
12
Atherosclerosis
01/2024 - 08/2014
9
Cardiovascular Diseases (Cardiovascular Disease)
01/2024 - 03/2015
8
Coronary Disease (Coronary Heart Disease)
10/2023 - 10/2003
7
Coronary Artery Disease (Coronary Atherosclerosis)
06/2023 - 06/2009
6
Myocardial Infarction
12/2022 - 10/2003
4
Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2024 - 10/2018
3
Inflammation (Inflammations)
01/2024 - 01/2021
3
Hypertension (High Blood Pressure)
11/2023 - 10/2003
2
Hypercholesterolemia
11/2023 - 05/2020
2
Atherosclerotic Plaque (Atheroma)
10/2023 - 06/2009
2
Dyslipidemias (Dyslipidemia)
10/2023 - 01/2019
2
Hypertriglyceridemia
10/2023 - 01/2022
2
Aortic Valve Stenosis (Aortic Stenosis)
03/2023 - 01/2020
2
Stroke (Strokes)
11/2022 - 01/2019
2
Hyperlipoproteinemias
10/2020 - 01/2020
2
Chest Pain (Chest Pains)
11/2017 - 10/2003
2
Hyperlipidemias (Hyperlipidemia)
11/2017 - 01/2013
2
Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature
06/2015 - 03/2015
1
Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2023
1
Ischemic Stroke
12/2022
1
Calcinosis
11/2022
1
Peripheral Arterial Disease
05/2020
1
Type 2 Diabetes Mellitus (MODY)
01/2019
1
Myocardial Ischemia (Ischemic Heart Diseases)
10/2018
1
Carotid Artery Diseases
01/2016
1
Acute Coronary Syndrome
06/2015
1
Pathologic Constriction (Stenosis)
01/2013
Drug/Important Bio-Agent (IBA)
15
Lipoprotein(a)
IBA
10/2023 - 01/2013
8
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
11/2023 - 01/2013
7
oxidized low density lipoprotein
IBA
06/2023 - 01/2013
5
Lipids
IBA
11/2023 - 10/2003
5
LDL Cholesterol
IBA
03/2022 - 11/2017
4
Apolipoproteins A
IBA
10/2023 - 08/2014
4
evolocumab
IBA
10/2020 - 01/2019
3
Cholesterol
IBA
01/2024 - 10/2018
3
Proprotein Convertase 9
IBA
10/2023 - 10/2018
3
omega-Chloroacetophenone (Mace)
IBA
12/2022 - 02/2022
2
Triglycerides (Triacylglycerol)
IBA
10/2023 - 01/2019
2
Autoantibodies
IBA
03/2023 - 01/2021
2
LDL Lipoproteins (beta Lipoproteins)
IBA
12/2022 - 10/2018
2
Apoprotein(a) (Apolipoprotein (a))
IBA
01/2022 - 10/2018
2
Lipoproteins (Lipoprotein)
IBA
11/2017 - 01/2013
2
Atorvastatin (Lipitor)
FDA Link
11/2017 - 01/2013
2
Complement System Proteins (Complement)
IBA
06/2015 - 03/2015
1
LDL Receptors (LDL Receptor)
IBA
01/2024
1
Ezetimibe (Zetia)
FDA Link
11/2023
1
Fenofibrate (CiL)
FDA Link
Generic
10/2023
1
Immunoglobulin M (IgM)
IBA
03/2023
1
Apolipoprotein C-II (ApoC2)
IBA
01/2022
1
Antigen-Antibody Complex (Immune Complex)
IBA
01/2021
1
C-Reactive Protein
IBA
01/2021
1
Monoclonal Antibodies
IBA
10/2020
1
HDL Cholesterol
IBA
01/2019
1
Insulin (Novolin)
FDA Link
01/2019
1
PPAR alpha
IBA
01/2019
1
AN 12
IBA
11/2017
1
Rosuvastatin Calcium (Crestor)
FDA Link
06/2009
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
06/2009
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
06/2009
1
Apolipoproteins
IBA
10/2003
Therapy/Procedure
6
Blood Component Removal (Apheresis)
01/2020 - 01/2013
3
Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2022 - 01/2013
3
Percutaneous Coronary Intervention
11/2022 - 06/2009
3
Therapeutics
01/2020 - 06/2009
2
Myocardial Revascularization
06/2009 - 10/2003